Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nordlander

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
European Journal of Pharmacology|October 8, 1999
Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridineD Segawa, P O Sjöquist, M Nordlander, et al.
European Journal of Clinical Pharmacology|April 17, 1999
Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusionH Ericsson, C Fakt, L Höglund, et al.
British Journal of Clinical Pharmacology|May 21, 1999
Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteersH Ericsson, C Fakt, A Jolin-Mellgård, et al.
British Journal of Anaesthesia|November 30, 2000
Pharmacokinetics and pulmonary extraction of clevidipine, a new vasodilating ultrashort-acting dihydropyridine, during cardiopulmonary bypassA Vuylsteke, Q Milner, H Ericsson, et al.
European Heart Journal|June 14, 2003
The effect of a neuropeptide Y Y1 receptor antagonist in patients with angina pectorisL Gullestad, T Bjurø, L Aaberge, et al.
European Journal of Anaesthesiology|September 17, 2003
Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgeryA V V Powroznyk, A Vuylsteke, C Naughton, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
European Journal of Pharmacology|October 8, 1999
Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridineD Segawa, P O Sjöquist, M Nordlander, et al.
European Journal of Clinical Pharmacology|April 17, 1999
Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusionH Ericsson, C Fakt, L Höglund, et al.
British Journal of Clinical Pharmacology|May 21, 1999
Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteersH Ericsson, C Fakt, A Jolin-Mellgård, et al.
British Journal of Anaesthesia|November 30, 2000
Pharmacokinetics and pulmonary extraction of clevidipine, a new vasodilating ultrashort-acting dihydropyridine, during cardiopulmonary bypassA Vuylsteke, Q Milner, H Ericsson, et al.
European Heart Journal|June 14, 2003
The effect of a neuropeptide Y Y1 receptor antagonist in patients with angina pectorisL Gullestad, T Bjurø, L Aaberge, et al.
European Journal of Anaesthesiology|September 17, 2003
Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgeryA V V Powroznyk, A Vuylsteke, C Naughton, et al.
Pageof 6